Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print October 7, 2009
(Neurology 2009, doi:10.1212/WNL.0b013e3181c17ea8)
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Morris, B.
Right arrow Articles by King, A. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morris, B.
Right arrow Articles by King, A. A.
Related Collections
Right arrow Childhood stroke
Right arrow All Cerebrovascular disease/Stroke
Right arrow Radiation therapy-tumor
Right arrow All Pediatric
Right arrow Pediatric stroke; see Cerebrovascular Disease/ Childhood stroke
Received May 4, 2009
Accepted August 20, 2009

Cerebrovascular disease in childhood cancer survivors. A Children's Oncology Group Report

B. Morris MD*, S. Partap MD, K. Yeom MD, I. C. Gibbs MD, P. G. Fisher MD, and A. A. King MD, MPH

From the Divisions of Neurology and Cancer Survivorship (B.M.), St. Jude Children's Research Hospital, Memphis, TN; Departments of Neurology (S.P., P.G.F.), Radiology (K.Y.), Radiation Oncology (I.C.G.), and Pediatrics (P.G.F.), Stanford University School of Medicine, CA; and Program of Occupational Therapy and Department of Pediatrics (A.A.K.), Washington University School of Medicine and St. Louis Children's Hospital, MO.


* To whom correspondence should be addressed. E-mail: brannon.morris{at}stjude.org.

Background: Curative therapy for childhood cancer has dramatically improved over past decades. Therapeutic radiation has been instrumental in this success. Unfortunately, irradiation is associated with untoward effects, including stroke and other cerebrovascular disease (CVD). The Children's Oncology Group (COG) has developed guidelines for screening survivors at risk for persistent or late sequelae of cancer therapy.

Objective: This review summarizes the pathophysiology and relevant manifestations of radiation-induced CVD and outlines the specific patient groups at risk for early-onset stroke. The reader will be alerted to the availability of the COG recommendations for monitoring, and, when applicable, specific screening and treatment recommendations will be highlighted.

Methods: A multidisciplinary task force critically reviewed the existing literature and scored the evidence to establish the current COG guidelines for monitoring health of survivors treated with head and neck irradiation.

Results: Previous head and neck exposure to therapeutic radiation is associated with latent CVD and increased risk for stroke in some patient groups. Common manifestations of radiation-induced CVD includes steno-occlusive disease, moyamoya, aneurysm, mineralizing microangiopathy, vascular malformations, and strokelike migraines.

Conclusions: Risk for stroke is increased in survivors of pediatric CNS tumors, Hodgkin lymphoma, and acute lymphoblastic leukemia who received radiation to the brain and/or neck. As the population of survivors ages, vigilance for stroke and cerebrovascular disease needs to continue based on specific exposures during curative cancer therapy.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by AAN Enterprises, Inc.